Selected article for: "prognostic factor and severe disease"
Author: Nardo, Alexander D.; Schneeweiss‐Gleixner, Mathias; Bakail, May; Dixon, Emmanuel D.; Lax, Sigurd F.; Trauner, Michael
Title: Pathophysiological mechanisms of liver injury in COVID‐19
  • Cord-id: xl7ofz69
  • Document date: 2020_11_29
    • ID: xl7ofz69
    Snippet: The recent outbreak of coronavirus disease 2019 (COVID‐19), caused by the Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) has resulted in a world‐wide pandemic. Disseminated lung injury with the development of acute respiratory distress syndrome (ARDS) is the main cause of mortality in COVID‐19. Although liver failure does not seem to occur in the absence of pre‐existing liver disease, hepatic involvement in COVID‐19 may correlate with overall disease severity and se
    Document: The recent outbreak of coronavirus disease 2019 (COVID‐19), caused by the Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) has resulted in a world‐wide pandemic. Disseminated lung injury with the development of acute respiratory distress syndrome (ARDS) is the main cause of mortality in COVID‐19. Although liver failure does not seem to occur in the absence of pre‐existing liver disease, hepatic involvement in COVID‐19 may correlate with overall disease severity and serve as a prognostic factor for the development of ARDS. The spectrum of liver injury in COVID‐19 may range from direct infection by SARS‐CoV‐2, indirect involvement by systemic inflammation, hypoxic changes, iatrogenic causes such as drugs and ventilation to exacerbation of underlying liver disease. This concise review discusses the potential pathophysiological mechanisms for SARS‐CoV‐2 hepatic tropism as well as acute and possibly long‐term liver injury in COVID‐19.

    Search related documents:
    Co phrase search for related documents
    • acute phase and liver cell: 1, 2, 3, 4, 5
    • acute phase and liver congestion: 1, 2
    • acute phase and liver damage: 1, 2, 3, 4, 5, 6
    • acute phase and liver disease: 1, 2, 3, 4, 5, 6
    • acute phase and liver enzyme: 1, 2
    • acute phase and liver injury: 1, 2, 3, 4, 5, 6, 7, 8
    • acute phase and liver injury risk factor: 1
    • acute phase and long term follow study: 1
    • acute phase and lower right: 1
    • acute phase and lung carcinoma: 1
    • acute phase and macrovesicular steatosis: 1, 2
    • acute phase and macrovesicular steatosis microvesicular: 1
    • liver disease and long term liver: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • liver disease and luminal thrombosis: 1, 2
    • liver disease and lung carcinoma: 1
    • liver disease and macrovesicular steatosis: 1, 2
    • liver enzyme and long term liver: 1
    • liver injury and long term follow study: 1
    • liver injury and long term liver: 1